The UCLA Diabetes Program is an internationally recognized team of physicians, nurses and nutritionists providing the highest level of care to patients with diabetes mellitus. Our multidisciplinary group is located throughout the Los Angeles area and offers a personalized diabetes plan to meet the needs of all patients living with diabetes.
We offer a team-based approach providing care for all adults with diabetes, including types 1 and 2 and other less common forms such as gestational diabetes, MODY, cystic fibrosis related diabetes and diabetes after pancreas removal. Our providers align and work closely with other UCLA physicians skilled in the diagnosis and treatment of diabetic complications, creating a large, multidisciplinary network. More >
200 UCLA Medical Plaza, Suite 530
Los Angeles, CA 90095 (map)
310-825-7922
2020 Santa Monica Blvd, Suite 550
Santa Monica, CA 90404
310-828-1050
The Annual UCLA Diabetes Symposium is a one day CME program aimed at provding physicians and allied health professionals updates on the latest in diabetes care. Experts in Endocrinology and other specalties review current best practices in diabetes care as well as review treatment in related co morbidities. For more information, including program schedule and speakers, please visit the symposium registration link below.
Date: Saturday November 14, 2020
Venue: Loews Santa Monica Beach Hotel
The UCLA Diabetes Program invites you to the Healthy Living with Diabetes Patient Conference. This annual meeting, which started in 2015, aims to educate patients and members of the local community in diabetes research and care.
Join us for this empowering and motivating event designed for patients with diabetes and those at risk. The program includes a Product Fair as well as discussions in diabetes related research and care. We focus on both type 1 and 2 diabetes mellitus.
Date: Fall 2020
Venue: TBD
Drs. Rashmi Mullur, Matthew Freeby and colleagues published findings of cortical brain changes in type 2 diabetes mellitus in the Journal of Diabetes. More >
Drs. Vanessa Arguello Schmidt and Matthew Freeby received funding to study the risk of hypo- and hyperglycemia in patients receiving insulin or sulphonylureas in long-term care facilities.
Dr. Rachael Oxman has been awarded an EnVision CF Emerging leaders Endocrinology Program grant by the Cystic Fibrosis Foundation
Dr. Tannaz Moin published results from NEXT-D evaluating pre-diabetes care and rates of incident diabetes in BMJ Open Diabetes Research and Care. More >
